Bio Path Holdings Inc reports results for the quarter ended in December - Earnings Summary

Bio Path Holdings

31/03/2023 14:31

* Bio Path Holdings Inc  BPTH.OQ  reported a quarterly
adjusted
loss of 52 cents​​ per share for the quarter ended in December.
The lone analyst forecast for the quarter was for a loss of 45
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Bio Path Holdings Inc's reported EPS for the quarter was a
loss
of 52 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Bio Path Holdings Inc shares had risen by 13.2% this
quarter.
    * The company reported a quarterly loss of $3.97 million.
    * Wall Street's median 12-month price target for Bio Path
Holdings
Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 31 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.45          -0.52          Missed
 Sep. 30 2022      -0.45          -0.49          Missed
 Jun. 30 2022      -0.49          -0.42          Beat
 Mar. 31 2022      -0.45          -0.47          Missed